— Know what they know.
Not Investment Advice
Also trades as: 0JDM.L (LSE) · $vol 0M

IQV NYSE

IQVIA Holdings Inc.
1W: +4.7% 1M: +14.5% 3M: +31.5% YTD: -5.3% 1Y: +6.3% 3Y: -5.7% 5Y: -11.7%
$243.31
+30.09 (+14.11%)
 
Weekly Expected Move ±4.5%
$189 $199 $208 $217 $227
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 68 · $40.6B mcap · 159M float · 1.02% daily turnover · Short 48% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$40.6B
52W Range154.5-247.7184
Volume4,675,230
Avg Volume1,621,059
Beta1.20
Dividend
Analyst Ratings
36 Buy 7 Hold 1 Sell
Consensus Buy
Company Info
CEOAri Bousbib
Employees93,000
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2013-05-09
Websiteiqvia.com
2400 Ellis Road
Durham, NC 27703
US
919 998 2000
About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Recent Insider Trades

NameTypeSharesPriceDate
GOGGINS COLLEEN A A-Award 183 2026-07-14
Fasano Jim A-Award 195 2026-07-14
DANHAKL JOHN G A-Award 160 2026-07-14
Wims Morris Leslie A-Award 148 2026-07-14
Wims Morris Leslie A-Award 171 2026-05-07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms